Pancreatic Cancer Research

ResearcherSalk Institute for Biological StudiesActive in the last 2 years

Nicholas D. P. Cosford

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7228-4709; OpenAlex author ID A5039016268. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
1
Labs led
0
Collaborators
11
Papers, trials and grants by year

2019: 1 grant · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Leveraging autophagy and pyrimidine metabolism to target pancreatic cancer Co-author DOI 10.1101/2025.05.29.656904↗
  2. The autophagy initiating kinase ULK1 is required for pancreatic cancer cell growth and survival Co-author DOI 10.1101/2021.05.15.444304↗

Grants 1

  1. Pre-clinical Development of a ULK1/2 Inhibitor for Pancreatic Cancer AWARD pancan:2019-nicholas-cosford-phd-pre-clinical-development-of-a-ulk1-2-inh

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sonja N. Brun · 2 shared papers, 2021–2025 · strength 0.29
  2. Reuben Shaw · 2 shared papers, 2021–2025 · strength 0.29
  3. Dannielle D. Engle · 2 shared papers, 2021–2025 · strength 0.29
  4. Hervé Tiriac · 2 shared papers, 2021–2025 · strength 0.29
  5. Joel Encarnación-Rosado · 1 shared paper, 2025 · strength 0.17
  6. Christina G. Towers · 1 shared paper, 2025 · strength 0.17
  7. Christian M. Metallo · 1 shared paper, 2025 · strength 0.17
  8. Suzanne Dufresne · 1 shared paper, 2025 · strength 0.17
  9. Andrew M. Lowy · 1 shared paper, 2025 · strength 0.17
  10. Jan C. Lumibao · 1 shared paper, 2021 · strength 0.12
  11. Ronald M. Evans · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.